评估爱尔兰全科医生对永久性心房颤动患者使用口服抗凝剂和抗血小板治疗质量的试点研究

Sarah McErlean, John Broughan, Geoff McCombe, Ronan Fawsitt, Walter Cullen, Joe Gallagher
{"title":"评估爱尔兰全科医生对永久性心房颤动患者使用口服抗凝剂和抗血小板治疗质量的试点研究","authors":"Sarah McErlean, John Broughan, Geoff McCombe, Ronan Fawsitt, Walter Cullen, Joe Gallagher","doi":"10.1017/s1463423623000622","DOIUrl":null,"url":null,"abstract":"Aim: The aim of this pilot study is to determine the pattern of oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation (AF) in Irish general practice. Background: Worldwide, AF is the most common sustained cardiac arrhythmia in adults and poses a significant burden to patients, physicians and healthcare systems. There is a five-fold increased risk of stroke with AF, and AF-related strokes are associated with higher levels of both morbidity and mortality compared to other stroke subtypes. Thankfully, appropriate use of oral anticoagulation (OAC) for AF can reduce the risk of stroke by up to 64%. However, we know that patients are commonly undertreated with OAC, prescribed inappropriate doses of OAC and have prolonged use of an antiplatelet agent in addition to OAC without indication. Methods: A descriptive, cross-sectional observational study was undertaken. Proportionate sampling was used across 11 practices from the Ireland East practice-based research network. The general practitioners completed a report form on each patient provided by the research team by undertaking a retrospective chart review. Findings: Eleven practices participated with a total number of 1855 patients with AF. We received data on 153 patients. The main findings from this pilot project are that:<jats:list list-type=\"number\"> <jats:list-item> <jats:label>1.</jats:label> 11% of patients were undertreated with OAC </jats:list-item> <jats:list-item> <jats:label>2.</jats:label> 20 % of patients were on an incorrect non-vitamin K antagonist oral anticoagulant dose </jats:list-item> <jats:list-item> <jats:label>3.</jats:label> 28 patients (18%) were inappropriately prescribed combination antithrombotic therapy </jats:list-item> </jats:list> Undertreatment and underdosing of OAC expose patients to higher risk of thromboembolic events, bleeding and all-cause mortality. Prolonged combination antithrombotic therapy is associated with serious increased risk of bleeding with no additional stroke protection. This pilot project highlights several gaps between guidelines and clinical practice. By identifying these areas, we hope to develop a targeted quality improvement intervention using the electronic health records in general practice to improve the care that those with AF receive.","PeriodicalId":74493,"journal":{"name":"Primary health care research & development","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A pilot study to evaluate the quality of care in oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation in Irish general practice\",\"authors\":\"Sarah McErlean, John Broughan, Geoff McCombe, Ronan Fawsitt, Walter Cullen, Joe Gallagher\",\"doi\":\"10.1017/s1463423623000622\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The aim of this pilot study is to determine the pattern of oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation (AF) in Irish general practice. Background: Worldwide, AF is the most common sustained cardiac arrhythmia in adults and poses a significant burden to patients, physicians and healthcare systems. There is a five-fold increased risk of stroke with AF, and AF-related strokes are associated with higher levels of both morbidity and mortality compared to other stroke subtypes. Thankfully, appropriate use of oral anticoagulation (OAC) for AF can reduce the risk of stroke by up to 64%. However, we know that patients are commonly undertreated with OAC, prescribed inappropriate doses of OAC and have prolonged use of an antiplatelet agent in addition to OAC without indication. Methods: A descriptive, cross-sectional observational study was undertaken. Proportionate sampling was used across 11 practices from the Ireland East practice-based research network. The general practitioners completed a report form on each patient provided by the research team by undertaking a retrospective chart review. Findings: Eleven practices participated with a total number of 1855 patients with AF. We received data on 153 patients. The main findings from this pilot project are that:<jats:list list-type=\\\"number\\\"> <jats:list-item> <jats:label>1.</jats:label> 11% of patients were undertreated with OAC </jats:list-item> <jats:list-item> <jats:label>2.</jats:label> 20 % of patients were on an incorrect non-vitamin K antagonist oral anticoagulant dose </jats:list-item> <jats:list-item> <jats:label>3.</jats:label> 28 patients (18%) were inappropriately prescribed combination antithrombotic therapy </jats:list-item> </jats:list> Undertreatment and underdosing of OAC expose patients to higher risk of thromboembolic events, bleeding and all-cause mortality. Prolonged combination antithrombotic therapy is associated with serious increased risk of bleeding with no additional stroke protection. This pilot project highlights several gaps between guidelines and clinical practice. By identifying these areas, we hope to develop a targeted quality improvement intervention using the electronic health records in general practice to improve the care that those with AF receive.\",\"PeriodicalId\":74493,\"journal\":{\"name\":\"Primary health care research & development\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary health care research & development\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/s1463423623000622\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary health care research & development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/s1463423623000622","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本试点研究旨在确定爱尔兰全科医生中永久性心房颤动(房颤)患者使用口服抗凝剂和抗血小板药物的模式。研究背景:在全球范围内,房颤是成年人最常见的持续性心律失常,给患者、医生和医疗保健系统带来了沉重负担。与其他中风亚型相比,房颤相关中风的发病率和死亡率均较高。值得庆幸的是,心房颤动患者适当使用口服抗凝药(OAC)可将中风风险降低 64%。然而,我们知道患者通常对 OAC 的治疗不足,开出的 OAC 剂量不当,并且在无指征的情况下除 OAC 外还长期使用抗血小板药物。研究方法进行了一项描述性横断面观察研究。在爱尔兰东部以实践为基础的研究网络中的 11 家诊所按比例抽样。全科医生通过回顾性病历审查,对研究小组提供的每位患者填写一份报告表。研究结果共有 11 家诊所参与了这项研究,共有 1855 名房颤患者。我们收到了 153 名患者的数据。该试点项目的主要发现有 11% 的患者接受的 OAC 治疗不足 2. 20% 的患者使用的非维生素 K 拮抗剂口服抗凝剂剂量不正确 3. 28 名患者(18%)接受的联合抗血栓治疗处方不当 治疗不足和 OAC 剂量不足使患者面临血栓栓塞事件、出血和全因死亡的更高风险。延长联合抗血栓治疗时间会严重增加出血风险,但对中风却没有额外的保护作用。该试点项目强调了指南与临床实践之间的一些差距。通过找出这些差距,我们希望利用全科医生的电子健康记录制定有针对性的质量改进干预措施,以改善心房颤动患者所接受的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A pilot study to evaluate the quality of care in oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation in Irish general practice
Aim: The aim of this pilot study is to determine the pattern of oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation (AF) in Irish general practice. Background: Worldwide, AF is the most common sustained cardiac arrhythmia in adults and poses a significant burden to patients, physicians and healthcare systems. There is a five-fold increased risk of stroke with AF, and AF-related strokes are associated with higher levels of both morbidity and mortality compared to other stroke subtypes. Thankfully, appropriate use of oral anticoagulation (OAC) for AF can reduce the risk of stroke by up to 64%. However, we know that patients are commonly undertreated with OAC, prescribed inappropriate doses of OAC and have prolonged use of an antiplatelet agent in addition to OAC without indication. Methods: A descriptive, cross-sectional observational study was undertaken. Proportionate sampling was used across 11 practices from the Ireland East practice-based research network. The general practitioners completed a report form on each patient provided by the research team by undertaking a retrospective chart review. Findings: Eleven practices participated with a total number of 1855 patients with AF. We received data on 153 patients. The main findings from this pilot project are that: 1. 11% of patients were undertreated with OAC 2. 20 % of patients were on an incorrect non-vitamin K antagonist oral anticoagulant dose 3. 28 patients (18%) were inappropriately prescribed combination antithrombotic therapy Undertreatment and underdosing of OAC expose patients to higher risk of thromboembolic events, bleeding and all-cause mortality. Prolonged combination antithrombotic therapy is associated with serious increased risk of bleeding with no additional stroke protection. This pilot project highlights several gaps between guidelines and clinical practice. By identifying these areas, we hope to develop a targeted quality improvement intervention using the electronic health records in general practice to improve the care that those with AF receive.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信